Pseudomonas aeruginosa in the ICU: prevalence, resistance profile, and antimicrobial consumption
| Autor: | Ághata Cardoso da Silva Ribeiro, Márcia Terezinha Lonardoni Crozatti, Adilson Aderito da Silva, Rodrigo Spineli Macedo, Antonia Maria de Oliveira Machado, Antonio Távora de Albuquerque Silva |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | Revista da Sociedade Brasileira de Medicina Tropical, Vol 53 (2019) |
| Druh dokumentu: | article |
| ISSN: | 1678-9849 0037-8682 |
| DOI: | 10.1590/0037-8682-0498-2018 |
| Popis: | Abstract INTRODUCTION: Pseudomonas aeruginosa is one of the main pathogens causing infection in intensive care units (ICUs) and usually presents antimicrobial resistance. METHODS: Data were obtained from ICUs between 2010 and 2013. RESULTS: P. aeruginosa had a prevalence of 14.5% of which 48.7% were multidrug resistant. We observed increasing resistance to carbapenems and polymyxin B and growing consumption of aminoglycosides, meropenem, ceftazidime, and polymyxin B. The regression impact between resistance and consumption was significant with respect to amikacin, imipenem, meropenem, and polymyxin B. CONCLUSIONS: Monitoring antimicrobial consumption and resistant microorganisms should be reinforced to combat antimicrobial- and multi-drug resistance. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|